Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary InfectionsDaniel A. Sweeney, André C. Kalil, Tatiana Beresnev et al.|Open Forum Infectious Diseases|2023Cited by 9
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment TrialGail E. Potter, Pablo Tebas, Tyler Bonnett et al.|Annals of Internal Medicine|2022Cited by 6